293 related articles for article (PubMed ID: 7505875)
21. Transcutaneous immunization with a synthetic hexasaccharide-protein conjugate induces anti-Vibrio cholerae lipopolysaccharide responses in mice.
Rollenhagen JE; Kalsy A; Saksena R; Sheikh A; Alam MM; Qadri F; Calderwood SB; Kovác P; Ryan ET
Vaccine; 2009 Aug; 27(36):4917-22. PubMed ID: 19563890
[TBL] [Abstract][Full Text] [Related]
22. A Vibrio cholerae classical TcpA amino acid sequence induces protective antibody that binds an area hypothesized to be important for toxin-coregulated pilus structure.
Taylor RK; Kirn TJ; Meeks MD; Wade TK; Wade WF
Infect Immun; 2004 Oct; 72(10):6050-60. PubMed ID: 15385509
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of enteric-coated tablets as a whole cell inactivated vaccine candidate against Vibrio cholerae.
Fernández S; Año G; Castaño J; Pino Y; Uribarri E; Riverón LA; Cedré B; Valmaseda T; Falero G; Pérez JL; Infante JF; García LG; Solís RL; Sierra G; Talavera A
Travel Med Infect Dis; 2013; 11(2):103-9. PubMed ID: 23492079
[TBL] [Abstract][Full Text] [Related]
24. Construction of a recombinant live oral vaccine from a non-toxigenic strain of Vibrio cholerae O1 serotype inaba biotype E1 Tor and assessment of its reactogenicity and immunogenicity in the rabbit model.
Thungapathra M; Sharma C; Gupta N; Ghosh RK; Mukhopadhyay A; Koley H; Nair GB; Ghosh A
Immunol Lett; 1999 Jun; 68(2-3):219-27. PubMed ID: 10424424
[TBL] [Abstract][Full Text] [Related]
25. Immunogenicity and protective efficacy of Vibrio cholerae outer membrane vesicles in rabbit model.
Roy N; Barman S; Ghosh A; Pal A; Chakraborty K; Das SS; Saha DR; Yamasaki S; Koley H
FEMS Immunol Med Microbiol; 2010 Oct; 60(1):18-27. PubMed ID: 20528929
[TBL] [Abstract][Full Text] [Related]
26. Immunoglobulins in bile and serum of the rabbit associated with protection after Vibrio cholerae infection and vaccination.
Rijpkema SG; Jansen WH; Gielen H; Guinée PA
Microb Pathog; 1987 Nov; 3(5):365-75. PubMed ID: 2462153
[TBL] [Abstract][Full Text] [Related]
27. [Cholera vaccine].
Ehara M
Nihon Rinsho; 2005 May; 63 Suppl 5():625-30. PubMed ID: 15954420
[No Abstract] [Full Text] [Related]
28. Evaluation of the protective efficacy of Vibrio cholerae ghost (VCG) candidate vaccines in rabbits.
Eko FO; Schukovskaya T; Lotzmanova EY; Firstova VV; Emalyanova NV; Klueva SN; Kravtzov AL; Livanova LF; Kutyrev VV; Igietseme JU; Lubitz W
Vaccine; 2003 Sep; 21(25-26):3663-74. PubMed ID: 12922096
[TBL] [Abstract][Full Text] [Related]
29. Oral immunization with Salmonella typhi Ty21a-based clones expressing Vibrio cholerae O-antigen: serum bactericidal antibody responses in man in relation to pre-immunization antibody levels.
Attridge S
Vaccine; 1991 Dec; 9(12):877-82. PubMed ID: 1725837
[TBL] [Abstract][Full Text] [Related]
30. The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers.
García L; Jidy MD; García H; Rodríguez BL; Fernández R; Año G; Cedré B; Valmaseda T; Suzarte E; Ramírez M; Pino Y; Campos J; Menéndez J; Valera R; González D; González I; Pérez O; Serrano T; Lastre M; Miralles F; Del Campo J; Maestre JL; Pérez JL; Talavera A; Pérez A; Marrero K; Ledón T; Fando R
Infect Immun; 2005 May; 73(5):3018-24. PubMed ID: 15845509
[TBL] [Abstract][Full Text] [Related]
31. Human immune response to the 18-kDa outer-membrane antigen of Vibrio cholerae.
Sciortino CV
J Med Microbiol; 1993 Aug; 39(2):135-40. PubMed ID: 8345508
[TBL] [Abstract][Full Text] [Related]
32. Immunochemical characterization of an Ogawa-Inaba common antigenic determinant of Vibrio cholerae O1.
Villeneuve S; Boutonnier A; Mulard LA; Fournier JM
Microbiology (Reading); 1999 Sep; 145 ( Pt 9)():2477-2484. PubMed ID: 10517600
[TBL] [Abstract][Full Text] [Related]
33. Intestinal and systemic immune responses in humans after oral immunization with a bivalent B subunit-O1/O139 whole cell cholera vaccine.
Jertborn M; Svennerholm AM; Holmgren J
Vaccine; 1996 Oct; 14(15):1459-65. PubMed ID: 8994322
[TBL] [Abstract][Full Text] [Related]
34. Immune response to the mannose-sensitive hemagglutinin in patients with cholera due to Vibrio cholerae O1 and O0139.
Qadri F; Jonson G; Begum YA; Wennerås C; Albert MJ; Salam MA; Svennerholm AM
Clin Diagn Lab Immunol; 1997 Jul; 4(4):429-34. PubMed ID: 9220159
[TBL] [Abstract][Full Text] [Related]
35. Immunization of mice with vibrio cholerae outer-membrane vesicles protects against hyperinfectious challenge and blocks transmission.
Bishop AL; Tarique AA; Patimalla B; Calderwood SB; Qadri F; Camilli A
J Infect Dis; 2012 Feb; 205(3):412-21. PubMed ID: 22147790
[TBL] [Abstract][Full Text] [Related]
36. Immunogenicity of liposome-associated and refined antigen oral cholera vaccines in Thai volunteers.
Chaicumpa W; Chongsa-nguan M; Kalambaheti T; Wilairatana P; Srimanote P; Makakunkijcharoen Y; Looareesuwan S; Sakolvaree Y
Vaccine; 1998 Apr; 16(7):678-84. PubMed ID: 9562686
[TBL] [Abstract][Full Text] [Related]
37. Immunizing adult female mice with a TcpA-A2-CTB chimera provides a high level of protection for their pups in the infant mouse model of cholera.
Price GA; Holmes RK
PLoS Negl Trop Dis; 2014 Dec; 8(12):e3356. PubMed ID: 25474636
[TBL] [Abstract][Full Text] [Related]
38. Investigation into immunological responses against a native recombinant CTB whole-cell Vibrio cholerae vaccine in a rabbit model.
Boustanshenas M; Bakhshi B; Ghorbani M
J Appl Microbiol; 2013 Feb; 114(2):509-15. PubMed ID: 23082752
[TBL] [Abstract][Full Text] [Related]
39. Effect of chemical and heat inactivation on the antigenicity and immunogenicity of Vibrio cholerae.
Cryz SJ; Fürer E; Germanier R
Infect Immun; 1982 Oct; 38(1):21-6. PubMed ID: 7141690
[TBL] [Abstract][Full Text] [Related]
40. Immunogenicity of Vibrio cholerae O1 toxin-coregulated pili in experimental and clinical cholera.
Hall RH; Losonsky G; Silveira AP; Taylor RK; Mekalanos JJ; Witham ND; Levine MM
Infect Immun; 1991 Jul; 59(7):2508-12. PubMed ID: 1711017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
